Published in Verh Dtsch Ges Inn Med on January 01, 1973
Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation (1997) 4.09
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol (1998) 3.03
Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris. Acute results and incidence of restenosis during 6-month follow-up. Circulation (1990) 2.05
The natural history of aortic valve stenosis. Eur Heart J (1988) 1.72
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation (1998) 1.54
Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry. Z Kardiol (2004) 1.53
Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment. J Am Coll Cardiol (1999) 1.49
[The therapy of coronary heart disease. The current aspects]. Dtsch Med Wochenschr (1991) 1.39
Percutaneous coronary interventions using a new 5 French guiding catheter: results of a prospective study. Catheter Cardiovasc Interv (2001) 1.39
[The recanalization of the chronically occluded infarct vessel in single-vessel coronary disease. The reduction of cardiac events in long-term clinical follow-up]. Dtsch Med Wochenschr (1995) 1.39
Prognosis and possible presymptomatic manifestations of congestive cardiomyopathy (COCM). Postgrad Med J (1978) 1.28
Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation (1999) 1.18
Prognostic significance of late ventricular potentials after acute myocardial infarction. Eur Heart J (1983) 1.15
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT). Eur Heart J (1999) 1.10
Recording of left atrial potentials from pulmonary artery in man. Br Heart J (1980) 1.09
In vivo evaluation of the Lillehei-Kaster heart valve prosthesis. Ann Thorac Surg (1976) 1.07
Effects of verapamil on sinus node function in man. Eur J Cardiol (1978) 1.04
Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg (1999) 1.01
[Diagnostic and prognostic value of endomyocardial biopsy in patients with congestive cardiomyopathy (author's transl)]rdiomyopathy(author. Dtsch Med Wochenschr (1975) 1.00
Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation. J Cardiovasc Electrophysiol (2000) 1.00
Influence of sampling site and flow area on cardiac output measurements by Doppler echocardiography. J Am Coll Cardiol (1987) 0.99
Sinus node recovery time and calculated sinoatrial conduction time in normal subjects and patients with sinus node dysfunction. Circulation (1977) 0.98
Improvement of coronary vasodilatation capacity through single LDL apheresis. Atherosclerosis (1998) 0.95
The definition of heart failure. Eur Heart J (1983) 0.94
Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin. Circulation (1998) 0.94
Exercise performance in hypertrophic cardiomyopathies. Eur Heart J (1983) 0.93
Non-invasive detection of late potentials in man--a new marker for ventricular tachycardia. Eur Heart J (1981) 0.93
[Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man (author's transl)]. Z Kardiol (1981) 0.93
Arrhythmias in hypertrophic obstructive and non-obstructive cardiomyopathy. Eur Heart J (1983) 0.91
Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake. Cor Vasa (1985) 0.91
Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy. Eur Heart J (1983) 0.90
Late complications in patients with Björk-Shiley and St. Jude Medical heart valve replacement. Circulation (1983) 0.89
Results of heart transplantation in patients with preexisting malignancies. Am J Cardiol (1997) 0.89
Propafenone--a new antiarrhythmic drug. Eur Heart J (1980) 0.89
[Low-dose enalapril in severe chronic heart failure]. Z Kardiol (1991) 0.89
[The etiology, course and prognosis of dilated cardiomyopathy]. Z Kardiol (1982) 0.89
[Differential diagnosis of cyanosis. Familial methemoglobin-reductase deficiency]. Med Welt (1971) 0.89
Accuracy of Doppler echocardiography in quantification of left to right shunts in adult patients with atrial septal defect. J Am Coll Cardiol (1988) 0.89
Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. Z Kardiol (2005) 0.88
Death due to transprosthetic catheterization of a Björk-Shiley prosthesis in the aortic position. Am J Cardiol (1986) 0.88
Prosthetic valve endocarditis: clinical findings and management. Eur Heart J (1984) 0.87
Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area. Catheter Cardiovasc Interv (1999) 0.87
[Effect of alcohol on the heart including alcoholic cardiomyopathy]. Internist (Berl) (1978) 0.87
Molecular and electrophysiological evidence for "remodeling" of the L-type Ca2+ channel in persistent atrial fibrillation in humans. Z Kardiol (2000) 0.87
Manifestation of severe coronary heart disease after anabolic drug abuse. Clin Cardiol (1996) 0.86
[Significance of electrocardiography in the diagnosis and course observation of patients with congestive cardiomyopathy]. Z Kardiol (1974) 0.86
Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris. Circulation (1995) 0.86
[Course observations of hypertrophic obstructive myocardiopathy]. Z Kardiol (1976) 0.86
Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia. J Cardiovasc Pharmacol (1981) 0.85
Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation. Am J Cardiol (1990) 0.84
[Improved coronary vasodilator capacity by drug lipid lowering therapy in patients in the early stage of coronary atherosclerosis with reduced coronary reserves and moderate LDL hypercholesteremia]. Z Kardiol (1998) 0.84
[Cholestasis after antiarrhythmic therapy with propafenone]. Dtsch Med Wochenschr (1984) 0.83
[Which rhythm disturbances react to beta blockaders?]. Cardiology (1978) 0.83
[Effect of flecainide on chronic ventricular arrhythmias (author's transl)]. Z Kardiol (1982) 0.83
[Percutaneous mitral valvulotomy with the Inoue balloon in over 65-year-old patients--acute results and short-term follow-up in comparison with younger patients]. Z Kardiol (1995) 0.83
Surgical treatment of ventricular tachycardias. Complete versus partial encircling endocardial ventriculotomy. J Thorac Cardiovasc Surg (1984) 0.83
Late outcome of survivors of idiopathic ventricular fibrillation. Am J Cardiol (1998) 0.83
[Twiddler-Syndrome in a subpectoral implanted unipolar cardioverter-defibrillator]. Z Kardiol (1998) 0.82
[Congestive cardiomyopathy]. Med Welt (1973) 0.82
[Metastasizing round-cell sarcoma of the right atrium]. Dtsch Med Wochenschr (1991) 0.82
Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol (1999) 0.82
[Hemodynamics of the pulmonary circulation during a multistep exercise test in healthy subjects]. Med Welt (1976) 0.82
Streptokinase-induced activation of the kallikrein-kinin system and of the contact phase in patients with acute myocardial infarction. J Cardiovasc Pharmacol (1998) 0.82
Ventricular fibrillation induced by a unipolar implanted pacemaker (cathodal stimulation). Am Heart J (1976) 0.82
[Obstructive myocardiopathy]. Z Kreislaufforsch (1971) 0.82
Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment. Int J Cardiol (1999) 0.82
Effect of a single element subcutaneous array electrode added to a transvenous electrode configuration on the defibrillation field and the defibrillation threshold. Pacing Clin Electrophysiol (1998) 0.81
Doppler versus contrast echocardiography for diagnosis of tricuspid regurgitation. Am J Cardiol (1985) 0.81
[Primary pulmonary hypertension]. Z Kardiol (1976) 0.81
[Diagnostic significance of various parameters of sinus node function (author's transl)]. Z Kardiol (1979) 0.81
Prevalence of late potentials in patients with and without ventricular tachycardia: correlation with angiographic findings. Am J Cardiol (1982) 0.81
Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. Am J Cardiol (1984) 0.81
Regional myocardial free fatty acid extraction in normal and ischemic myocardium. Circulation (1988) 0.81
Aortic valve surgery following previous coronary artery bypass grafting. Impact of calcification and leaflet movement. Int J Cardiol (1998) 0.81
The effect of premature atrial depolarization on sinus node automaticity in man. Circulation (1976) 0.81
Percutaneous coronary excimer laser angioplasty: initial clinical results. Lancet (1989) 0.81
[Blood coagulation and fibrinolysis in arteriosclerosis]. Z Kardiol (1999) 0.80
Ventricular septal defect. Circulation (1968) 0.80
Five-year results after randomized mitral valve replacement with Björk-Shiley. Lillehei-Kaster, and Starr-Edwards prostheses. Thorac Cardiovasc Surg (1983) 0.80
[Indications for coronary angiography in patients with acquired heart valve diseases with reference to risk factors]. Z Kardiol (1987) 0.80
Influence of heart rate on systolic time intervals: effects of atrial pacing versus dynamic exercise. Clin Cardiol (1981) 0.80
[Echocardiographic determination of the severity of mitral stenosis by the mitral valve closure index (author's transl)]. Z Kardiol (1979) 0.80
Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction. J Am Coll Cardiol (1998) 0.80
Reoperations for malfunction of heart valve prostheses, especially with endocarditis. Thorac Cardiovasc Surg (1987) 0.79
[Bundle of His extrasystoles as a cause for A-V block and junctional tachycardia (author's transl)]. Z Kardiol (1981) 0.79